Andrew Dudum compensation by year
Hims & Hers Health Summary Compensation Table · all 7 fiscal years held| Component | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Salary | $253,750 | $527,187 | $573,875 | $600,000 | $612,040 | $572,917 | $494,792 |
| Bonus | $0 | $0 | $1,600,203 | $0 | $0 | $0 | $0 |
| Stock awards | $0 | $2,842,399 | $13,053,177 | $2,824,999 | $11,116,592 | $22,708,162 | $10,635,352 |
| Option awards | $0 | $23,106,043 | — | $6,296,219 | $1,305,179 | $0 | $11,000,000 |
| Non-equity incentive | $0 | $100,203 | — | $1,092,329 | $1,200,000 | $1,144,998 | $585,763 |
| Pension and deferred compensation | $0 | $0 | — | — | $0 | $0 | $0 |
| All other | $0 | $0 | $3,000 | $3,000 | $167,600 | $183,000 | $243,000 |
| Total | $253,750 | $26,575,832 | $15,230,255 | $10,816,547 | $14,401,411 | $24,609,077 | $22,958,907 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Hims & Hers Health, Inc. DEF 14A filed April 28, 2026, accession 0001773751-26-000060, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Hims & Hers Health, Inc. filed document, accession 0001773751-26-000060. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 670,769 | $21,779,869 | — |
| PSU | 511,061 | $16,594,151 | — |
| PSU | 397,001 | $12,890,622 | — |
| RSU | 248,955 | $8,083,569 | — |
| RSU | 177,233 | $5,754,756 | — |
| RSU | 35,242 | $1,144,308 | — |
| Option | 557,244 | — | $34.71 |
| Option | 521,410 | — | $5.01 |
| Option | 67,020 | — | $11.53 |
| Option | 43,451 | — | $5.01 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Hims & Hers Health, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
14 Form 4 lines since the FY2025 proxy (filed April 28, 2026)current to 2026-11-06 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-08-27 | Other | — | 977,566 | $0.00 | 103,406 |
| 2026-08-25 | Gift | — | 463,289 | $0.00 | 0 |
| 2026-08-14 | Exercise or conversion derivative | — | 35,447 | $0.00 | 70,893 |
| 2026-08-14 | Exercise or conversion | — | 154,993 | — | 1,112,036 |
| 2026-08-14 | Tax withholding | — | 78,859 | $28.15 | 1,033,177 |
| 2026-08-14 | Exercise or conversion derivative | — | 74,530 | $0.00 | 447,179 |
| 2026-08-14 | Exercise or conversion derivative | — | 19,151 | $0.00 | 191,504 |
| 2026-08-14 | Exercise or conversion derivative | — | 25,865 | $0.00 | 362,114 |
The 8 most recent of 14 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Hims & Hers Health’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Mohamed Elshenawy | Chief Technology Officer | $60,869,746 |
| Andrew Dudum · this page | Chief Executive Officer and Chairman | $22,958,907 |
| Nader Kabbani | Former Chief Operating Officer | $14,862,305 |
| Yemi Okupe | Chief Financial Officer | $8,398,808 |
| Melissa Baird | Former Chief Operating Officer | $8,392,871 |
| Mike Chi | Chief Operating Officer (previously Chief Commercial Officer) | $7,727,713 |
| Soleil Boughton | Chief Legal Officer | $4,796,709 |
Board service
Hims & Hers Health board · FY2021–FY2025How this board is paid
Company policy: Hims & Hers Health pays directors a $40,000 cash retainer and $200,000 in RSUs. As stated in Hims & Hers Health's FY2025 proxy.
The full Hims & Hers Health compensation record
free company briefThis page is one person within Hims & Hers Health's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Hims & Hers Health proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Hims & Hers Health's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Hims & Hers Health's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order HIMS
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.